• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Reduced Accuracy of Intake Screening Questionnaires Tied to Quality Metrics.摄入筛查问卷准确性降低与质量指标有关。
Ann Fam Med. 2023 Sep-Oct;21(5):444-447. doi: 10.1370/afm.3019.
2
Validity of the PROMIS depression and anxiety common metrics in an online sample of Australian adults.澳大利亚成年人在线样本中 PROMIS 抑郁和焦虑通用指标的有效性。
Qual Life Res. 2018 Sep;27(9):2453-2458. doi: 10.1007/s11136-018-1905-5. Epub 2018 Jun 5.
3
Examining the psychometric properties of brief screening measures of depression and anxiety in chronic pain: The Patient Health Questionnaire 2-item and Generalized Anxiety Disorder 2-item.考察慢性疼痛中简短抑郁和焦虑筛查测量工具的心理计量学特性:患者健康问卷 2 项和广泛性焦虑障碍 2 项。
Pain Pract. 2022 Apr;22(4):478-486. doi: 10.1111/papr.13107. Epub 2022 Mar 12.
4
Examining brief and ultra-brief anxiety and depression screening methods in a real-world epilepsy clinic sample.在真实世界的癫痫诊所样本中检查简短和超简短的焦虑和抑郁筛查方法。
Epilepsy Behav. 2021 May;118:107943. doi: 10.1016/j.yebeh.2021.107943. Epub 2021 Apr 8.
5
Feasibility and utility of screening for depression and anxiety disorders in patients with cardiovascular disease.对心血管疾病患者进行抑郁和焦虑症筛查的可行性及实用性。
Circ Cardiovasc Qual Outcomes. 2013 Jul;6(4):498-504. doi: 10.1161/CIRCOUTCOMES.111.000049. Epub 2013 Jun 11.
6
Validation of brief screening measures for depression and anxiety in young people with substance use disorders.验证用于物质使用障碍的年轻人的抑郁和焦虑的简短筛查措施。
J Affect Disord. 2021 Mar 1;282:1021-1029. doi: 10.1016/j.jad.2021.01.005. Epub 2021 Jan 7.
7
Examination of the best cut-off points of PHQ-2 and GAD-2 for detecting depression and anxiety in Italian cardiovascular inpatients.探讨 PHQ-2 和 GAD-2 在意大利心血管住院患者中检测抑郁和焦虑的最佳截断值。
Psychol Health. 2021 Sep;36(9):1088-1101. doi: 10.1080/08870446.2020.1830093. Epub 2020 Oct 7.
8
Examining the optimal cutoff values of HADS, PHQ-9 and GAD-7 as screening instruments for depression and anxiety in irritable bowel syndrome.探讨 HADS、PHQ-9 和 GAD-7 作为肠易激综合征患者抑郁和焦虑筛查工具的最佳截断值。
Neurogastroenterol Motil. 2021 Dec;33(12):e14161. doi: 10.1111/nmo.14161. Epub 2021 May 3.
9
Screening male prisoners for depression and anxiety with the PHQ-9 and GAD-7 at NHS Healthcheck: patterns of symptoms and caseness threshold.用 PHQ-9 和 GAD-7 对 NHS Healthcheck 中的男性囚犯进行抑郁和焦虑筛查:症状模式和病例阈值。
BMC Psychiatry. 2021 Sep 9;21(1):446. doi: 10.1186/s12888-021-03453-2.
10
What Proportion of Patients With Musculoskeletal Sarcomas Demostrate Symptoms of Depression or Anxiety?有多少患有肌肉骨骼肉瘤的患者表现出抑郁或焦虑症状?
Clin Orthop Relat Res. 2022 Nov 1;480(11):2148-2160. doi: 10.1097/CORR.0000000000002295. Epub 2022 Jun 30.

引用本文的文献

1
Assessment of Misinterpretation of Regulation by Compliance Professionals: A Multimethod Study.合规专业人员对法规误读的评估:一项多方法研究。
Perm J. 2025 Jun 16;29(2):3-11. doi: 10.7812/TPP/24.086. Epub 2025 Mar 4.

本文引用的文献

1
The Solution Shop and the Production Line - The Case for a Frameshift for Physician Practices.解决方案商店与生产线——医师执业模式转变的案例
N Engl J Med. 2022 Jun 30;386(26):2452-2453. doi: 10.1056/NEJMp2202511. Epub 2022 Jun 25.
2
Persistent depressive symptoms during COVID-19: a national, population-representative, longitudinal study of U.S. adults.新冠疫情期间的持续性抑郁症状:一项针对美国成年人的全国性、具有人口代表性的纵向研究。
Lancet Reg Health Am. 2022 Jan;5:100091. doi: 10.1016/j.lana.2021.100091. Epub 2021 Oct 4.
3
National and State Trends in Anxiety and Depression Severity Scores Among Adults During the COVID-19 Pandemic - United States, 2020-2021.在 COVID-19 大流行期间美国成年人焦虑和抑郁严重程度评分的全国和州趋势-2020-2021 年。
MMWR Morb Mortal Wkly Rep. 2021 Oct 8;70(40):1427-1432. doi: 10.15585/mmwr.mm7040e3.
4
Frequency of Administration of Standardized Screening Questions in Federally Qualified Health Centers.在联邦合格健康中心中标准化筛查问题的实施频率。
JAMA Intern Med. 2021 Sep 1;181(9):1253-1255. doi: 10.1001/jamainternmed.2021.2503.
5
Accuracy of the PHQ-2 Alone and in Combination With the PHQ-9 for Screening to Detect Major Depression: Systematic Review and Meta-analysis.单独使用 PHQ-2 与 PHQ-9 联合使用进行筛查以检测重度抑郁症的准确性:系统评价和荟萃分析。
JAMA. 2020 Jun 9;323(22):2290-2300. doi: 10.1001/jama.2020.6504.
6
Psychometric analysis of the Generalized Anxiety Disorder scale (GAD-7) in primary care using modern item response theory.使用现代项目反应理论对基层医疗中广泛性焦虑障碍量表(GAD-7)进行心理测量分析。
PLoS One. 2017 Aug 3;12(8):e0182162. doi: 10.1371/journal.pone.0182162. eCollection 2017.
7
Screening for anxiety disorders with the GAD-7 and GAD-2: a systematic review and diagnostic metaanalysis.使用广泛性焦虑障碍量表-7(GAD-7)和广泛性焦虑障碍量表-2(GAD-2)筛查焦虑症:一项系统评价与诊断性荟萃分析
Gen Hosp Psychiatry. 2016 Mar-Apr;39:24-31. doi: 10.1016/j.genhosppsych.2015.11.005. Epub 2015 Nov 18.
8
Poverty and mental health: how do low-income adults and children fare in psychotherapy?贫困与心理健康:经济贫困的成年人和儿童在心理治疗中的状况如何?
J Clin Psychol. 2013 Feb;69(2):115-26. doi: 10.1002/jclp.21951. Epub 2012 Dec 20.
9
Validation of PHQ-2 and PHQ-9 to screen for major depression in the primary care population.PHQ-2 和 PHQ-9 用于在初级保健人群中筛查重度抑郁症的验证。
Ann Fam Med. 2010 Jul-Aug;8(4):348-53. doi: 10.1370/afm.1139.
10
The Patient Health Questionnaire-2: validity of a two-item depression screener.患者健康问卷-2:一项两项抑郁症筛查工具的效度
Med Care. 2003 Nov;41(11):1284-92. doi: 10.1097/01.MLR.0000093487.78664.3C.

摄入筛查问卷准确性降低与质量指标有关。

Reduced Accuracy of Intake Screening Questionnaires Tied to Quality Metrics.

机构信息

AllianceChicago, Chicago, Illinois

AllianceChicago, Chicago, Illinois.

出版信息

Ann Fam Med. 2023 Sep-Oct;21(5):444-447. doi: 10.1370/afm.3019.

DOI:10.1370/afm.3019
PMID:37748897
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10519752/
Abstract

Clinical workflows that prioritize repetitive patient intake screening to meet performance metrics may have unintended consequences. This retrospective analysis of electronic health record data from 24 Federally Qualified Health Centers assessed effectiveness and accuracy of the 2-item Patient Health Questionnaire (PHQ-2) for depression screening and Generalized Anxiety Disorder 2 (GAD-2) for anxiety screening from 2019 to 2021. Scores of over 91% of PHQ-2 and GAD-2 tests indicated low likelihood of depression or anxiety, which diverged markedly from published literature on screening outcomes. Visit-based screenings linked to performance metrics may not be delivering the intended value in a real-world setting and risk distracting clinical effort from other high value activities.

摘要

临床工作流程优先进行重复的患者录入筛查以满足绩效指标,可能会产生意想不到的后果。本研究对 24 个联邦合格健康中心的电子健康记录数据进行回顾性分析,评估了 2019 年至 2021 年间使用 PHQ-2(2 项患者健康问卷)进行抑郁筛查和 GAD-2(广泛性焦虑障碍 2 项)进行焦虑筛查的效果和准确性。超过 91%的 PHQ-2 和 GAD-2 测试得分表明抑郁或焦虑的可能性较低,这与已发表的筛查结果文献明显不同。与绩效指标相关的基于就诊的筛查可能在现实环境中无法提供预期的价值,并有可能分散临床精力,使其无法从事其他高价值活动。